Alpha Cognition Inc.
ACOG · XNASCIK 1655923fmd_1EHF67WGF3GTJTF8E8A0J9AAZYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 14 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | – | – | 10 |
| Cost of revenue | – | – | 1 |
| Provision for credit losses | – | 0 | – |
| Gross profit | – | – | 10 |
| Research and development | 5 | 4 | 2 |
| Selling, general and administrative | – | 8 | 29 |
| Total operating expenses | 10 | 12 | 33 |
| Operating income | (10) | (12) | (23) |
| Interest expense | 0 | 0 | – |
| Interest and investment income | 0 | 0 | – |
| Other non-operating income (expense) | (4) | (3) | 2 |
| Income before taxes | – | (15) | (21) |
| Net income | (14) | (15) | (21) |
| Net income to common shareholders | (14) | (15) | (21) |